These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2093110)

  • 21. In vitro activity of tigecycline, tetracycline and fluoroquinolones against Brucella melitensis.
    Kilic S; Dizbay M; Cabadak H
    J Chemother; 2008 Feb; 20(1):33-7. PubMed ID: 18390405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.
    Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV
    Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin and rifampicin versus doxycycline and rifampicin in the treatment of brucellosis.
    Agalar C; Usubutun S; Turkyilmaz R
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):535-8. PubMed ID: 10517189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of brucellosis associated with corynebacterium parvum infection in mice with antibiotics (tetracycline, ampicillin, trimethoprim-sulfamethoxazole)].
    Philippon A; Kazmierczak A; Névot P
    Ann Inst Pasteur (Paris); 1972 Sep; 123(3):349-62. PubMed ID: 4639772
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice.
    N T; B N; O O; D D; J B
    BMC Complement Altern Med; 2018 May; 18(1):144. PubMed ID: 29724202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinolones for brucellosis: treating old diseases with new drugs.
    Pappas G; Christou L; Akritidis N; Tsianos EV
    Clin Microbiol Infect; 2006 Sep; 12(9):823-5. PubMed ID: 16882286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
    Ilhan Z; Solmaz H; Ekin IH
    J Vet Med Sci; 2013; 75(8):1035-40. PubMed ID: 23545462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model.
    Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV
    Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical manifestations and treatment of patients with acute brucellosis caused by Br. abortus].
    Bukin VN; Tolokonskaia NP
    Klin Med (Mosk); 1981 Sep; 59(9):78-80. PubMed ID: 6796752
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal cyst infection caused by Brucella abortus.
    Öncü S; Saylak Ö; Köseoğlu K; Öztürk B; Eşiyok A; Çörekli E; Sakarya S
    Ren Fail; 2013; 35(2):302-4. PubMed ID: 23176669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis.
    Keramat F; Ranjbar M; Mamani M; Hashemi SH; Zeraati F
    Trop Doct; 2009 Oct; 39(4):207-10. PubMed ID: 19762571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors.
    Kutlu M; Ergin Ç; Şen-Türk N; Sayin-Kutlu S; Zorbozan O; Akalın Ş; Şahin B; Çobankara V; Demirkan N
    J Infect Dev Ctries; 2015 Feb; 9(2):141-8. PubMed ID: 25699488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
    Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
    Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.
    Liu ZG; Di DD; Wang M; Liu RH; Zhao HY; Piao DR; Zhao ZZ; Hao YQ; Du YN; Jiang H; Cui BY; Xia XZ
    BMC Infect Dis; 2018 Jan; 18(1):43. PubMed ID: 29338693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic Brucella Infection Induces Selective and Persistent Interferon Gamma-Dependent Alterations of Marginal Zone Macrophages in the Spleen.
    Machelart A; Khadrawi A; Demars A; Willemart K; De Trez C; Letesson JJ; Muraille E
    Infect Immun; 2017 Nov; 85(11):. PubMed ID: 28808159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of brucellosis presenting with urinary tract infection].
    Uncu H; Demiroğlu YZ; Gül U; Güvel S; Turunç T; Cokaloğlu S; Arslan H
    Mikrobiyol Bul; 2006 Jul; 40(3):275-8. PubMed ID: 17001859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rifampicin and tetracycline in the treatment of experimental brucellosis in mice].
    Philippon A; Kazmierczak A
    Ann Inst Pasteur (Paris); 1972 Sep; 123(3):459-62. PubMed ID: 4565367
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
    Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
    J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.